[i] Now there are an estimated 300 CRISPR therapies in the pipeline, most of which are in early development for a range of diseases,[ii] including diabetes, HIV/AIDS and several types of cancer ...
MarketBeat on MSN26d
MaxCyte: Building the Future of Cell and Gene Therapy InnovationFor cell therapy, they help engineer immune cells like CAR-T cells to fight cancer. Gene editing tools like CRISPR/Cas ... Casgevy enables CRISPR/Cas-9 to edit the BCL11A gene in stem cells to produce ...
For cell therapy, they help engineer immune cells like CAR-T cells to fight cancer. Gene editing tools ... Casgevy enables CRISPR/Cas-9 to edit the BCL11A gene in stem cells to produce fetal ...
The FDA approved betibeglogene autotemcel (beti-cel; Zynteglo) for adult and pediatric patients with transfusion-dependent ...
Crispr Therapeutics AG has revenue declines but holds strong financials. Promising Sickle Cell therapy & 2025 data readouts ...
Researchers have been "making great inroads" in precision medicine, and a 15 percent cap on indirect costs could quash the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results